DaVita (DVA) stock
NYSE
As of the Nov 5, 2026 close (U.S. Eastern)
Events and reference metrics · 1
- Market cap
- $12.3B
- As of Nov 5, 2026
- P/E
- 13.33x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- 0.87x
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
- Market cap
- $12.3B
- As of Nov 5, 2026
- P/E
- 13.33x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- 0.87x
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 5, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
13.33x
P/B
—
P/S
0.87x
Earnings and dividend metrics▾
Earnings
EPS
$14.62
Earnings per share
BPS
—
Book value per share
ROE
—
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $14.62 per share.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 4.6% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $3.42B+4.6%
$3.26B
Jul–Sep '24
$3.42B
Jul–Sep '25
$3.58B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Oct 29, 2026.
- Earnings per share increased 66.7% from the same quarter a year earlier.
- Revenue increased 4.6% from the same quarter a year earlier.
- Operating income decreased 1.4% from the same quarter a year earlier.
- Net income increased 48.7% from the same quarter a year earlier.
Filed Oct 29, 2026 · 10-Q · SEC EDGAR · View original
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- BERKSHIRE HATHAWAY INC10% owner · Oct 27, 2026Open-market sale382,563 shares · $69.0MAvg. price $180.430528,314,666 shares held after
- Maughan David PaulChief Operating Officer, DKC · Sep 22, 2026Shares withheld for taxes7,501 shares · $1.4MAvg. price $182.3486,604 shares held after
- Pullin Dennis WDirector · Aug 15, 2026Grant or award278 shares · $0Avg. price $02,949 shares held after
- Hollar Jason M.Director · Aug 15, 2026Grant or award278 shares · $0Avg. price $06,883 shares held after
- Schechter Adam HDirector · Aug 15, 2026Grant or award278 shares · $0Avg. price $05,970 shares held after
- Arway Pamela MDirector · Aug 15, 2026Grant or award278 shares · $0Avg. price $027,223 shares held after
- Moore Gregory J.Director · Aug 15, 2026Grant or award278 shares · $0Avg. price $08,091 shares held after
- YALE PHYLLIS RDirector · Aug 15, 2026Grant or award278 shares · $0Avg. price $09,803 shares held after
- DESOER BARBARA JDirector · Aug 15, 2026Grant or award278 shares · $0Avg. price $0278 shares held after
- Schoppert Wendy LeeDirector · Aug 15, 2026Grant or award278 shares · $0Avg. price $0278 shares held after
- BERKSHIRE HATHAWAY INC10% owner · Jul 31, 2026Open-market sale182,980 shares · $36.5MAvg. price $199.54828,697,229 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary10-QThe company said it recorded goodwill and other asset impairment charges of $62 million related to its China business in Q3 2026. It said the decline in estimated fair value was driven by unfavorable changes in reimbursement rates and operating conditions across its non-dialysis hospital services.Published Oct 29, 2026 · Filed Oct 29, 2026Read the summary →
- AI summary8-KDaVita said consolidated revenue for Q3 2026 was $3.578 billion, operating income was $499 million, and adjusted operating income was $561 million, with the quarter ended September 30. Diluted earnings per share were $3.40 and adjusted diluted earnings per share were $3.82.Published Oct 29, 2026 · Filed Oct 29, 2026Read the summary →
- AI summary8-KDaVita said it entered into an Eighth Amendment to its Credit Agreement on November 24, 2025, with JPMorgan Chase Bank, N.A. serving as administrative agent, collateral agent and swingline lender, as of August 12, 2019.Published Oct 14, 2026 · Filed Nov 25, 2025Read the summary →
- The company said it recorded goodwill and other asset impairment charges of $62 million related to its China business in Q3 2026. It said the decline in estimated fair value was driven by unfavorable changes in reimbursement rates and operating conditions across its non-dialysis hospital services.Read the full analysis →
- DaVita said consolidated revenue for Q3 2026 was $3.578 billion, operating income was $499 million, and adjusted operating income was $561 million, with the quarter ended September 30. Diluted earnings per share were $3.40 and adjusted diluted earnings per share were $3.82.Read the full analysis →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
DaVita (DVA) stock information
NYSE
DaVita (DVA) is listed on NYSE. Its market capitalization is about $12.3B. On trailing-twelve-month earnings the P/E ratio is 13.33. These figures are computed in-house from official filings and are reference information only.
DaVita — frequently asked questions
- What is the P/E ratio of DaVita (DVA)?
- On a trailing-twelve-month basis, DVA trades at a P/E ratio of 13.33. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of DaVita?
- DVA has a market capitalization of about $12.3B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.